NOVABAY PHARMACEUTICALS INC's ticker is and the CUSIP is 66987P300. A total of 16 filers reported holding NOVABAY PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,315 | – | 85,145 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 141,000 | $239,700 | 0.00% |
| Addison Advisors LLC | 4 | $7 | 0.00% |
| Blue Trust, Inc. | 37 | $0 | 0.00% |
| Renaissance Technologies | 18,723 | $32 | 0.00% |
| ROYAL BANK OF CANADA | 15 | $0 | 0.00% |
| UBS Group AG | 182 | $309 | 0.00% |
| WealthPLAN Partners, LLC | 1 | $2 | 0.00% |
| OSAIC HOLDINGS, INC. | 37 | $63 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 86 | $146 | 0.00% |
| WELLS FARGO & COMPANY/MN | 10 | $17 | 0.00% |